Image -
PIP-2404-2,Dorte-Gram.jpg
Pila Pharma was founded in Malmö, Sweden in 2014 by Native Dane, Dorte X. Gram. With a background as a veterinarian, Dorte X. Gram has been researcher at Novo Nordisk, where she was part of the obesity research team. She was the scientist that identified and highlighted the molecule that would later become Semaglutide, which today is the pillar of Ozempic and Wegovy, Novo Nordisk’s injectable obesity drugs. Photo: Pila Pharma.
go to media item
- License:
- Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
- File format:
- .jpg
- Size:
- 5760 x 3372, 10.2 MB
